Industry Reports
CPhI Annual Report expert warns innovation is being hindered by regulators
CPhI Worldwide the world’s largest pharma event – taking place in Madrid October (9-11) and organized by UBM (part of Informa plc) – releases the first part of its 6th Annual Report with a stark warning from Girish Malhotra,...
Industry Reports
Middle East and Africa pharma economy to reach US$38.8bn by 2021
CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply...
Industry Reports
Genstar Capital to Acquire CRF Health from Vitruvian Partners andCombine with Bracket
Genstar Capital, a leading investor in healthcare technology and services companies,is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the...
Industry Reports
Sovereign announces the sale of Xendo to ProPharma Group – first exit from SCLP IV
Sovereign Capital Partners, the UK private equity Buy & Build specialist, is pleased to announce the realisation of its investment in Xendo - a leading independent consultancy and project management organisation in the fields of (bio)pharmaceutical products, medical devices...
Industry Reports
Korea finished drug market growth driven by generics
The Korean pharma market is experiencing significant growth in finished drug products, according to CPhI Korea. Over the last 12 months, market conditions have spurred a strong expansion in exports of finished formulations, driven primarily by an expanding domestic...
Industry Reports
Bosch plans to sell its packaging business
After intensively and thoroughly considering all its strategic options, Bosch has decided to look for a buyer for its packaging machinery business (PA), more specifically the pharmaceuticals and food units of the Packaging Technology division. With...
Industry Reports
Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site
Recipharm and Sanofi announced that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
